Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D London

Showing results (541-550 of 590) with videos related to

Pageof 59
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 20, 2008
Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigaretteArthur L Brody, Mark A Mandelkern, Richard E Olmstead, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1996
Peptide T and glucose metabolism in AIDS dementia complexV L Villemagne, R L Phillips, X Liu, et al.
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|January 23, 2016
A longitudinal mediational study on the stability of alexithymia among alcohol-dependent outpatients in cognitive-behavioral therapyFred Arne Thorberg, Ross McD Young, Karen A Sullivan, et al.
Addiction Biology|June 27, 2022
Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trialErica N Grodin, Steven J Nieto, Lindsay R Meredith, et al.
Journal of Neurochemistry|August 26, 1999
Synthesis and characterization of binding of 5-[76Br]bromo-3-[[2(S)-azetidinyl]methoxy]pyridine, a novel nicotinic acetylcholine receptor ligand, in rat brainW Sihver, K J Fasth, A G Horti, et al.
Journal of Cognitive Neuroscience|January 11, 2014
Decomposing decision components in the stop-signal task: a model-based approach to individual differences in inhibitory controlCorey N White, Eliza Congdon, Jeanette A Mumford, et al.
Drug and Alcohol Dependence|May 25, 2007
Cerebral metabolism and mood in remitted opiate dependenceIgor I Galynker, Daniel Eisenberg, John A Matochik, et al.
Neuroimage. Clinical|January 14, 2016
Placebo analgesia: Self-report measures and preliminary evidence of cortical dopamine release associated with placebo responseJohanna M Jarcho, Natasha A Feier, Jennifer S Labus, et al.
Life Sciences|December 31, 1998
In vivo imaging of brain nicotinic acetylcholine receptors with 5-[123I]iodo-A-85380 using single photon emission computed tomographyS I Chefer, A G Horti, K S Lee, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 28, 2004
Pharmacological and toxicological evaluation of 2-fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-F-A-85380), a ligand for imaging cerebral nicotinic acetylcholine receptors with positron emission tomographyD Bruce Vaupel, Srihari R Tella, David L Huso, et al.
Pageof 59

Showing results (541-550 of 590) with videos related to

Sort By:
Pageof 59
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 20, 2008
Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigaretteArthur L Brody, Mark A Mandelkern, Richard E Olmstead, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1996
Peptide T and glucose metabolism in AIDS dementia complexV L Villemagne, R L Phillips, X Liu, et al.
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|January 23, 2016
A longitudinal mediational study on the stability of alexithymia among alcohol-dependent outpatients in cognitive-behavioral therapyFred Arne Thorberg, Ross McD Young, Karen A Sullivan, et al.
Addiction Biology|June 27, 2022
Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trialErica N Grodin, Steven J Nieto, Lindsay R Meredith, et al.
Journal of Neurochemistry|August 26, 1999
Synthesis and characterization of binding of 5-[76Br]bromo-3-[[2(S)-azetidinyl]methoxy]pyridine, a novel nicotinic acetylcholine receptor ligand, in rat brainW Sihver, K J Fasth, A G Horti, et al.
Journal of Cognitive Neuroscience|January 11, 2014
Decomposing decision components in the stop-signal task: a model-based approach to individual differences in inhibitory controlCorey N White, Eliza Congdon, Jeanette A Mumford, et al.
Drug and Alcohol Dependence|May 25, 2007
Cerebral metabolism and mood in remitted opiate dependenceIgor I Galynker, Daniel Eisenberg, John A Matochik, et al.
Neuroimage. Clinical|January 14, 2016
Placebo analgesia: Self-report measures and preliminary evidence of cortical dopamine release associated with placebo responseJohanna M Jarcho, Natasha A Feier, Jennifer S Labus, et al.
Life Sciences|December 31, 1998
In vivo imaging of brain nicotinic acetylcholine receptors with 5-[123I]iodo-A-85380 using single photon emission computed tomographyS I Chefer, A G Horti, K S Lee, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 28, 2004
Pharmacological and toxicological evaluation of 2-fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-F-A-85380), a ligand for imaging cerebral nicotinic acetylcholine receptors with positron emission tomographyD Bruce Vaupel, Srihari R Tella, David L Huso, et al.
Pageof 59